We are thrilled to announce that our US market expansion has reached a pivotal milestone. Two of our development teams have successfully presented their innovations at Morgan Stanley Investment Management’s Technology Center in Manhattan.
🗽🇺🇸
Both the concepts and the functional prototypes received exceptionally positive feedback from Morgan Stanley’s expert panels. We are moving forward with two breakthrough solutions:
🛡️ Revolutionary Antibacterial Surface Treatment: A unique material and proprietary process that reduces the risk of bacterial infections from surface contact to under 20%. This technology sets a new benchmark for safety in high-traffic environments.
🩺 AI-Powered Smart Stethoscope: A cutting-edge diagnostic tool capable of capturing real-time ECG and pulmonary function data. The device streams these metrics—alongside preliminary diagnostics from an integrated AI Agent—directly to the physician’s workstation for immediate clinical insight.
The Road Ahead ⭐️
Building on this momentum, we have collaborated with Morgan Stanley’s specialists to finalize a three-stage Market Entry Route Map for the remainder of the year. This strategic roadmap will serve as our blueprint for scaling these technologies across the US healthcare and industrial landscapes.
A huge congratulations to the teams for their relentless work, and a sincere thank you to the Morgan Stanley team for their invaluable professional guidance.
The journey has just begun. 📈
hashtagInnovation hashtagHealthTech hashtagUSMarketEntry hashtagMorganStanley hashtagMedTech hashtagAI hashtagBiotech hashtagGlobalBusiness hashtagNewYorkTech
